MDWD Stock Analysis: Buy, Sell, or Hold?
MDWD - MediWound Ltd.
$16.50
0.09 (0.55%)
▲
5d:
+0.24%
30d:
-6.88%
90d:
-6.88%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 27, 2026
8d
Get Alerted When MDWD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MDWD this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MDWD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MDWD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MDWD is currently trading at $16.50, which is considered slightly low relative to its 30-day fair value range of $16.43 to $17.46.
Technical Outlook: Technically, MDWD is in a downtrend. The price is currently testing key support at $16.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDWD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.33 (+90.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MDWD is in a downtrend. The price is currently testing key support at $16.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDWD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.33 (+90.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$16.43 -
$17.46
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 90.9% below Wall St target ($31.33)
Trading Range Analysis
30-Day Trading Range
$16.43 -
$17.46
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$16.03
Resistance Level
$17.56
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.56
Wall Street Target
$31.33
(+90.9%)
Revenue Growth (YoY)
-68.0%
Profit Margin
-140.8%
Share & Embed Analysis
Last updated: May 18, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDWD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 61 BUY |
